REQUEST A DEMO
Total
USD $0.00
« Back to previous page

Hungary Pharma and Healthcare Sector Report 2019/2020

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: August 2019
Pages: 75
Available in: English

The changing demographic and disease profiles of Hungary were the drivers of the expansion of health expenditure in recent years. As a result, the country spent 7.4% of its GDP on healthcare in 2016, still below the EU average. The government continued to play a major role, contributing around two-thirds of the total health spending. Nevertheless, the deficiencies of the public healthcare system coupled with the rising incomes in the country, propelled the demand for private medical services. This has also encouraged domestic sales of pharmaceuticals, especially OTC drugs. On the other hand, sales of prescription drugs, mostly innovative drugs, stagnated due to the state’s cost containment policies. This prompted drug makers to increasingly rely on foreign markets thus turning Hungary into the largest drug exporter in the CEE. In 2017 the country’s pharma trade surplus came to HUF 318bn.

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Hungary. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and pharmaceutical sector in Hungary
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in Hungary
  • Crystallise the forces both driving and restraining this sector in Hungary
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in Hungary
  • Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels)
Hungary Pharma and Healthcare Sector Report 2019/2020 - Page 1
Buy full report USD 495.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: customerenquiries@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

Hungary Pharma and Healthcare Sector Report 2019/2020 -  Page 3
Hungary Pharma and Healthcare Sector Report 2019/2020 -  Page 4
Hungary Pharma and Healthcare Sector Report 2019/2020 -  Page 21
Hungary Pharma and Healthcare Sector Report 2019/2020 -  Page 23
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?